In a collaborative project led by the University of Oxford, the ARTICULATE PRO study at the Nuffield Department of Surgical Sciences has today announced that another milestone has been achieved, as it has now expanded the deployment of AI in the prostate cancer pathway to three trusts, all using a computer-assisted diagnostic system called Paige Prostate Suite in the live clinical workflow across the three hospital sites.
Each hospital uses different digital pathology scanners and information systems and serves distinct patient populations—but are all adding Paige’s AI applications to their standard of care to determine the potential to improve patient outcomes against a background of rising instances of prostate cancer.
The Paige Prostate Suite is a diagnostic AI system comprised of three AI applications designed to help pathologists detect, grade and measure tumours in prostate biopsies and tissue samples. Pathologists at these three hospitals are assessing how Paige Prostate Suite impacts their clinical decision-making, pathology service delivery, and use of resources in a real-world setting. With this use across multiple hospitals, pathologists can assess the ways Paige’s AI technology can best serve patients, histopathologists, and hospital systems for prostate cancer diagnosis. This development is the latest achievement of the ARTICULATE PRO study, funded by the Accelerated Access Collaborative (AAC) Artificial Intelligence in Health and Care Award, overseen by the Department of Health and Social Care.
Read the full story on the Nuffield Department of Surgical Sciences.